£410k
+9%vs May 2024Active07637268Private limited companyLondon
ABIMMUNO LIMITED
Significant control: Teresa Marafioti (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Abimmuno Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Abimmuno Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ABIMMUNO LIMITED is an active private limited company (company number 07637268) incorporated on 17 May 2011, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 May 2025, showing net assets of £410k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 9% on the prior period (£375k).
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Dr. Teresa Marafioti
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 17 May 201115 yrs ago
- Next accounts due
- 28 February 2027in 127 days
- Confirmation statement due
- 31 May 2027in 219 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
0
vs May 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £410k | — | — | £136k | — | — | 0 |
| 31 May 2024 | £375k | — | — | £205k | — | — | 0 |
Current ratio4.01Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £410,262 at 31 May 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 4.01
- Incorporated five or more years agoIncorporated 17 May 2011
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 219 days
- Next accounts duein 127 days
- Accounts period endNet assets £410k · micro accounts
- Accounts period endNet assets £375k · micro accounts
- Incorporated
08
Similar companies in London
- NANOGENICS LIMITEDLondon · inc. May 2011
- COLBE R&D LIMITEDLondon · inc. May 2011
- SYNTHESIS MED CHEM (UK) LIMITEDLondon · inc. May 2011
- SYNTHACE LIMITEDLondon · inc. May 2011
- OXFORD GENETICS LTDLondon · inc. Apr 2011
- VITAE BIOTECH LTDLondon · inc. Jun 2011
All companies incorporated on 17 May 2011 · in May 2011.
09
Reminders for ABIMMUNO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.